138 related articles for article (PubMed ID: 24262709)
1. [Non-muscle invasive bladder cancer with multiple bone metastasis without local invasion : a case report].
Sasaki Y; Oi H; Oyama T; Kagawa J; Komori M; Senzaki T; Fukawa T; Takahashi H; Takemura M; Yamaguchi K; Yamamoto Y; Izaki H; Takahashi M; Fukumori T; Kanayama HO
Hinyokika Kiyo; 2013 Oct; 59(10):669-72. PubMed ID: 24262709
[TBL] [Abstract][Full Text] [Related]
2. A Phase I Trial of Intravesical Cabazitaxel, Gemcitabine and Cisplatin for the Treatment of Nonmuscle Invasive bacillus Calmette-Guérin Unresponsive or Recurrent/Relapsing Urothelial Carcinoma of the Bladder.
DeCastro GJ; Sui W; Pak JS; Lee SM; Holder D; Kates MM; Virk RK; Drake CG; Anderson CB; James B; Abate-Shen CT; McKiernan JM
J Urol; 2020 Aug; 204(2):247-253. PubMed ID: 32118506
[TBL] [Abstract][Full Text] [Related]
3. Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): a systematic review.
Shelley MD; Jones G; Cleves A; Wilt TJ; Mason MD; Kynaston HG
BJU Int; 2012 Feb; 109(4):496-505. PubMed ID: 22313502
[TBL] [Abstract][Full Text] [Related]
4. [Metastases of Urothelial Carcinoma with Trophoblastic Differentiation that Responded to Combination Chemotherapy with Gemcitabine and Oxaliplatin : A Case Report].
Uchida M; Kawai K; Kurobe M; Ikeda A; Kandori S; Endo T; Miyagawa T; Kojima T; Tsutsumi M; Nishiyama H
Hinyokika Kiyo; 2018 Feb; 64(2):55-61. PubMed ID: 29684950
[TBL] [Abstract][Full Text] [Related]
5. Metastatic non-muscle invasive bladder cancer with meningeal carcinomatosis: case report of an unexpected response.
Teyssonneau D; Daste A; Dousset V; Hoepffner JL; Ravaud A; Gross-Goupil M
BMC Cancer; 2017 May; 17(1):323. PubMed ID: 28494780
[TBL] [Abstract][Full Text] [Related]
6. Intravesical gemcitabine for high risk, nonmuscle invasive bladder cancer after bacillus Calmette-Guérin treatment failure.
Sternberg IA; Dalbagni G; Chen LY; Donat SM; Bochner BH; Herr HW
J Urol; 2013 Nov; 190(5):1686-91. PubMed ID: 23665400
[TBL] [Abstract][Full Text] [Related]
7. A rare case of synchronous bilateral epididymal and testicular metastases of urothelial carcinoma of the bladder after intravesical bacillus Calmette-Guérin.
Nishiyama N; Ikehata Y; Okuno N; Sasahara M; Sakamaki I; Yamamoto Y; Kitamura H
Int Cancer Conf J; 2021 Jan; 10(1):59-62. PubMed ID: 33489703
[TBL] [Abstract][Full Text] [Related]
8. The impact of intravesical gemcitabine and 1/3 dose Bacillus Calmette-Guérin instillation therapy on the quality of life in patients with nonmuscle invasive bladder cancer: results of a prospective, randomized, phase II trial.
Gontero P; Oderda M; Mehnert A; Gurioli A; Marson F; Lucca I; Rink M; Schmid M; Kluth LA; Pappagallo G; Sogni F; Sanguedolce F; Schiavina R; Martorana G; Shariat SF; Chun F
J Urol; 2013 Sep; 190(3):857-62. PubMed ID: 23545101
[TBL] [Abstract][Full Text] [Related]
9. A novel treatment strategy for newly diagnosed high-grade T1 bladder cancer: Gemcitabine and cisplatin adjuvant chemotherapy-A single-institution experience.
Yang GL; Zhang LH; Liu Q; Wang ZL; Duan XH; Huang YR; Bo JJ
Urol Oncol; 2017 Feb; 35(2):38.e9-38.e15. PubMed ID: 28040419
[TBL] [Abstract][Full Text] [Related]
10. Midterm follow-up (3 years) confirms and extends short-term results of intravesical gemcitabine as bladder-preserving treatment for non-muscle-invasive bladder cancer after BCG failure.
Hurle R; Contieri R; Casale P; Morenghi E; Saita A; Buffi N; Lughezzani G; Colombo P; Frego N; Fasulo V; Paciotti M; Guazzoni G; Lazzeri M
Urol Oncol; 2021 Mar; 39(3):195.e7-195.e13. PubMed ID: 33268275
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine in bladder cancer.
El Karak F; Flechon A
Expert Opin Pharmacother; 2007 Dec; 8(18):3251-6. PubMed ID: 18035967
[TBL] [Abstract][Full Text] [Related]
12. Intravesical gemcitabine for non-muscle invasive bladder cancer.
Jones G; Cleves A; Wilt TJ; Mason M; Kynaston HG; Shelley M
Cochrane Database Syst Rev; 2012 Jan; 1():CD009294. PubMed ID: 22259002
[TBL] [Abstract][Full Text] [Related]
13. [A Case of Long Survival in Aggressively Growing Small Cell Carcinoma of the Bladder Successfully Treated by Combined Chemotherapy of Methotrexate, Etoposide and Cisplatin].
Jikuya R; Washimi K; Yasui M; Hashizume A; Tatenuma T; Mizuno N; Muraoka K; Umemoto S; Kawai M; Kishida T
Hinyokika Kiyo; 2017 Jun; 63(6):245-249. PubMed ID: 28694418
[TBL] [Abstract][Full Text] [Related]
14. [Distant Metastasis in Patients with Non-Muscle Invasive Bladder Cancer without Local Recurrence : Report of Two Rare Cases].
Kida K; Shimizu Y; Ogawa K; Kanamaru S; Ito N
Hinyokika Kiyo; 2018 Jun; 64(6):271-275. PubMed ID: 30064166
[TBL] [Abstract][Full Text] [Related]
15. [Metastatic micropapillary variant of urothelial carcinoma of the urinary bladder responding to gemcitabine and cisplatin chemotherapy].
Ishii T; Matsubara T; Taira H; Hiratsuka Y
Nihon Hinyokika Gakkai Zasshi; 2013 May; 104(3):540-4. PubMed ID: 23819368
[TBL] [Abstract][Full Text] [Related]
16. [Bladder cancer with skin metastasis: a case report].
Segawa N; Kotake Y; Hamada S; Takahara K; Azuma H; Katsuoka Y; Tsuji M
Hinyokika Kiyo; 2006 Sep; 52(9):711-4. PubMed ID: 17040057
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancer.
Fujita N; Hatakeyama S; Momota M; Kido K; Narita T; Tobisawa Y; Yoneyama T; Yamamoto H; Imai A; Ito H; Yoneyama T; Hashimoto Y; Yoshikawa K; Ohyama C
Urol Oncol; 2020 Aug; 38(8):684.e17-684.e24. PubMed ID: 32278732
[TBL] [Abstract][Full Text] [Related]
18. Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological Responses.
Pfister C; Gravis G; Fléchon A; Soulié M; Guy L; Laguerre B; Mottet N; Joly F; Allory Y; Harter V; Culine S;
Eur Urol; 2021 Feb; 79(2):214-221. PubMed ID: 32868138
[TBL] [Abstract][Full Text] [Related]
19. EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.
Babjuk M; Böhle A; Burger M; Capoun O; Cohen D; Compérat EM; Hernández V; Kaasinen E; Palou J; Rouprêt M; van Rhijn BWG; Shariat SF; Soukup V; Sylvester RJ; Zigeuner R
Eur Urol; 2017 Mar; 71(3):447-461. PubMed ID: 27324428
[TBL] [Abstract][Full Text] [Related]
20. Feasiblity study of gemcitabine and cisplatin administered every two weeks in patients with advanced urothelial tumors and impaired renal function.
Carles J; Suárez C; Mesía C; Nogué M; Font A; Doménech M; Suárez M; Tusquets I; Gallén M; Albanell J; Fabregat X
Clin Transl Oncol; 2006 Oct; 8(10):755-7. PubMed ID: 17074675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]